` WST (West Pharmaceutical Services Inc) vs S&P 500 Comparison - Alpha Spread

WST
vs
S&P 500

Over the past 12 months, WST has underperformed S&P 500, delivering a return of -34% compared to the S&P 500's 10% growth.

Stocks Performance
WST vs S&P 500

Loading
WST
S&P 500
Add Stock
www.alphaspread.com

Performance Gap
WST vs S&P 500

Loading
WST
S&P 500
Difference
www.alphaspread.com

Performance By Year
WST vs S&P 500

Loading
WST
S&P 500
Add Stock

Competitors Performance
West Pharmaceutical Services Inc vs Peers

S&P 500
WST
0KHE
TMO
DHR
207940
Add Stock

West Pharmaceutical Services Inc
Glance View

Economic Moat
Narrow
Market Cap
15.7B USD
Industry
Life Sciences Tools & Services

Nestled in the heart of the pharmaceutical and healthcare industry is West Pharmaceutical Services Inc., a company that has woven itself into the fabric of drug delivery systems since its founding in 1923. This company, headquartered in Exton, Pennsylvania, operates with the precision of a Swiss watch, designing and manufacturing an array of cutting-edge containment and delivery solutions for injectable medicines. West's expertise is reflected in the products it develops—ranging from stoppers and seals for vials to advanced syringe and device technologies. Its robust research and development pipeline underscores a commitment to innovation, ensuring that new advances in drug delivery provide critical safety and efficacy for patients and healthcare professionals alike. West Pharmaceutical's business model revolves around partnering closely with pharmaceutical and biotechnology companies worldwide. This symbiotic relationship secures West's place at the forefront of global healthcare evolution. While the client companies focus on the complex process of drug formulation and therapeutic efficacy, West ensures that these drugs are delivered effectively and safely through its meticulously engineered components and systems. As a result, the company garners a revenue stream from a robust portfolio of products and services that cater to the long-term needs of its clients, helping them efficiently navigate the stringent regulatory environment. Through these partnerships and their resultant dividends, West Pharmaceutical Services continues to embed its name into the essential infrastructure of global health care.

WST Intrinsic Value
196.59 USD
Overvaluation 10%
Intrinsic Value
Price
Back to Top